Get the Stockscreener App
0.4809
5.09%
-0.0262
Harvard Bioscience Inc stock is traded at $0.4809, with a volume of 1.45M.
It is down -5.09% in the last 24 hours and down -14.05% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.5071
Open:
$0.5011
24h Volume:
1.45M
Relative Volume:
3.11
Market Cap:
$21.52M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-2.4045
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
-15.71%
1M Performance:
-14.05%
6M Performance:
+8.99%
1Y Performance:
-29.74%
1-Day Range:
$0.40
$0.51
1-Week Range:
$0.40
$0.576
52-Week Range:
$0.2813
$0.9458
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.4813 | 22.68M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
474.69 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.09 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.53 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
233.22 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.21 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com
HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus
Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus
HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com UK
Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget
Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView
HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative
Harvard Bioscience: Q4 Earnings Snapshot - kare11.com
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Yahoo Finance
Harvard Bioscience promotes Frost to CFO - Worcester Business Journal
Harvard Bioscience Amends Executive Employment Agreements for CEO John Duke and CFO Mark Frost – Key Terms and Provisions - Minichart
Harvard Bioscience Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Harvard Bioscience Updates Executive Contracts and Finance Leadership - TipRanks
Harvard Bioscience Announces Reverse Stock Split - 富途牛牛
Harvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight - Nasdaq
Aug Volume: Can Harvard Bioscience Inc grow without external funding2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Bank Watch: Can Harvard Bioscience Inc navigate macro headwindsTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split - Investing.com
Bull Bear: Does Harvard Bioscience Inc offer margin of safetyJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - baoquankhu1.vn
Harvard Bioscience Approves Reverse Stock Split to Regain Compliance - TipRanks
Harvard Bioscience Announces 1-for-10 Reverse Stock Split Effective March 13, 2026 - Quiver Quantitative
Harvard Bioscience announces reverse stock split - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Harvard Bioscience (HBIO) to Release Quarterly Earnings on Thursday - Defense World
Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum - The Manila Times
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - ChartMill
Aug Breakouts: Is Harvard Bioscience Inc stock trending bullishJuly 2025 Earnings & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is Harvard Bioscience Inc. a cyclical or defensive stockBond Market & Fast Gain Stock Tips - mfd.ru
Volume Report: Is Harvard Bioscience Inc exposed to political riskDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
What makes Harvard Bioscience Inc. stock attractive to growth fundsJuly 2025 Setups & Verified Trade Idea Suggestions - mfd.ru
Is Harvard Bioscience Inc. stock forming a triangle patternJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru
How Harvard Bioscience Inc. stock reacts to Fed rate cutsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - mfd.ru
HBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
HBIO Should I Buy - Intellectia AI
Is Harvard Bioscience Inc. forming a bullish divergenceWeekly Trade Analysis & High Accuracy Swing Trade Signals - mfd.ru
Why Harvard Bioscience Inc. stock could be next big winnerWeekly Profit Summary & Long Hold Capital Preservation Plans - mfd.ru
Harvard Bioscience reports Q4 revenue in line with guidance - Investing.com South Africa
HBIO Posts Strong Q4 Results with Positive Outlook for Future Gr - GuruFocus
Harvard Bioscience reports Q4 revenue in line with guidance By Investing.com - Investing.com Nigeria
Returns Recap: Will Harvard Bioscience Inc face regulatory challengesJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - baoquankhu1.vn
Harvard Bioscience (HBIO) Faces Strategic Evolution in Life Scie - GuruFocus
Harvard Bioscience Reports Strong Q4 Results and Growth Strategy - Intellectia AI
Harvard Bioscience Reports Preliminary Q4 Results and Outlines Growth Strategy for 2026 - Quiver Quantitative
Harvard Bioscience Announces Preliminary Fourth Quarter - GlobeNewswire
Harvard Bioscience to Close Holliston Manufacturing Facility as Part of Global Consolidation - Boston Real Estate Times
Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Below 200 Day Moving Average – Here’s Why - Defense World
Aug Chart Watch: Whats next for Harvard Bioscience Inc stockEarnings Overview Report & AI Driven Stock Reports - baoquankhu1.vn
Harvard Bioscience will move Holliston MA manufacturing out of state - MetroWest Daily News
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):